Remdesivir for the treatment of COVID-19: Clinical trials begins at the University of Nebraska
by Press Release from Outbreak News Today on (#4ZVJF)
A randomized, controlled clinical trial to evaluate the safety and efficacy of the investigational antiviral remdesivir in hospitalized adults diagnosed with coronavirus disease 2019 (COVID-19) has begun at the University of Nebraska Medical Center (UNMC) in Omaha. The trial regulatory sponsor is the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes ["]
The post Remdesivir for the treatment of COVID-19: Clinical trials begins at the University of Nebraska appeared first on Outbreak News Today.